(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
National Pharmaceutical Pricing Authority

New Delhi, the 11th January, 2023

ORDER
S. O. 194(E):- In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and
18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013
and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India the Ministry
of Chemicals and Fertilizers and in supersession of the Order of the Government of India in
the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No SO
1499(E) dated 30th March, 2022 in so far as it relates to formulation packs mentioned in the
table below, except in respect of things done or omitted to be done before such supersession,
the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the
price as specified in column (5) of the table herein below as ceiling price exclusive of goods
and services tax applicable, if any, in respect of the Scheduled formulation specified in the
corresponding entry in column (2) of the said Table with the dosage form & strength and unit
specified respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Name of the
Sl. Ceiling Price
Scheduled Dosage form and strength Unit
No. (Rs.)
Formulation
(1) (2) (3) (4) (5)
1 Levothyroxine Tablet 62.5mcg 1 Tablet 1.44
2 Ondansetron Tablet 4 mg 1 Tablet 4.58
3 Clindamycin Tablet 300mg 1 Tablet 16.92
4 Prednisolone Tablet 40mg 1 Tablet 3.04
5 Zoledronic acid Powder for Injection 4mg 1 Vial 2133.32
6 Adenosine Injection 3mg/mL 1 ML 82.81
7 Ciprofloxacin Drops 0.3 % 1 ML 1.37
8 Isoflurane Liquid for inhalation 1 ML 8.61
9 Cytosinearabinoside Injection 1000mg/vial 1 Vial 1008.07
10 Metronidazole Injection 500mg/100mL 1 ML 0.19
11 Ciprofloxacin Injection 200mg/100mL 1 ML 0.18
12 Amiodarone Injection 50mg/mL 1 ML 18.85
Lopinavir (A) +
13 Ritonavir(B) Tablet 200 mg (A) + 50mg (B) 1 Tablet 42.78
 Name of the
Sl. Ceiling Price
Scheduled Dosage form and strength Unit
No. (Rs.)
Formulation
Artemether (A) +
14 Lumefantrine(B) Tablet 40 mg (A) + 240 mg (B) 1 Tablet 16.09
15 Azithromycin Powder for Injection 500mg 1 Vial 182.58
16 Vancomycin Powder for Injection 500 mg 1 Vial 283.28
17 Vancomycin Powder for Injection 1000mg 1 Vial 419.40
18 Acyclovir Powder for Injection 250 mg 1 Vial 380.28
19 Methylergometrine Tablet 0.125mg 1 Tablet 7.97
20 Streptokinase Injection 15,00,000IU 1 Vial 1674.28
21 D-Penicillamine Capsule 250 mg 1 Capsule 13.96
22 Thiamine Tablet 100 mg 1 Tablet 3.98
23 Vancomycin Powder for Injection 250 mg 1 Vial 224.08
24 Etoposide Capsule 50mg 1 Capsule 50.51
25 Spironolactone Tablet 50mg 1 Tablet 3.90
26 Salbutamol Oral liquid 2mg/5mL 1 ML 0.16
27 Domperidone Oral Liquid 1mg/mL 1 ML 1.11
28 Amoxicillin Capsule 250mg 1 Capsule 2.18
29 Fluconazole Tablet 150mg 1 Tablet 10.76
30 Cetirizine Tablet 10mg 1 Tablet 1.68
31 Phenobarbitone Tablet 60mg 1 Tablet 1.69
Artesunate (A) +
Sulphadoxine - Combi pack (A+B) 1 Tablet 50mg 1 Combi
32 Pyrimethamine (B) (A) + 1Tablet (500mg + 25mg) (B) Pack 20.11
33 Hydrochlorothiazide Tablet 25 mg 1 Tablet 1.56
34 Efavirenz Tablet 600mg 1 Tablet 62.96
35 Chloroquine Tablet 150 mg 1 Tablet 1.04
36 Prednisolone Oral liquid 5mg/5mL(p) 1 ML 0.44
37 Prednisolone Oral liquid 15mg/5mL(p) 1 ML 0.77
38 Misoprostol Tablet 100mcg 1 Tablet 8.85
Tenofovir Disproxil
Fumarate (A) +
39 Lamivudine (B) Tablet 300mg (A) + 300mg(B) 1 Tablet 40.65
Tenofovir Disproxil
Fumarate (A)
+Lamivudine (B)+ Tablet 300mg(A)+ 300mg (B) +
40 Efavirenz(C) 600mg(C) 1 Tablet 91.72
Tenofovir Disproxil
41 Fumarate (TDF)* Tablet 300mg 1 Tablet 40.88
42 Lithium Tablet 300mg 1 Tablet 1.45
Amoxicillin (A) + Powder for Injection 500mg (A) +
43 Clavulanic acid (B) 100mg (B) 1 Vial 90.38
44 Streptomycin Powder for Injection 750 mg 1 Vial 9.01
 Name of the
Sl. Ceiling Price
Scheduled Dosage form and strength Unit
No. (Rs.)
Formulation
45 Bleomycin Powder for Injection 15units 1 Vial 604.14
46 Cyclophosphamide Powder for Injection 500mg 1 Vial 65.54
47 Dacarbazine Powder for Injection 500mg 1 Vial 462.71
48 Hydrochlorothiazide Tablet 12.5mg 1 Tablet 0.93
49 Cyclosporine Capsule 25 mg 1 Capsule 25.01
50 Acyclovir Powder for Injection 500 mg 1 Vial 471.29
51 Risperidone Oral liquid 1mg/mL 1 ML 1.97
52 Haloperidol Oral liquid 2mg/5mL 1 ML 2.00
53 Caffeine Oral liquid 20 mg/mL 1 ML 219.11
54 Cholecalciferol Oral liquid 400 IU/mL 1 ML 2.33
55 Temozolomide Capsule 100mg 1 Capsule 1345.52
56 Artesunate Powder for Injection 60 mg 1 Vial 218.26
57 Artesunate Powder for Injection 120mg 1 Vial 405.28
58 Diazepam Tablet 5 mg 1 Tablet 1.45
59 Levetiracetam Oral liquid 100 mg/mL (p) 1 ML 3.54
60 Mebendazole Oral liquid 100mg/5mL(p) 1 ML 0.75
61 Cefadroxil Oral liquid 125mg/5mL(p) 1 ML 0.61
62 Clarithromycin Oral liquid 125mg/5mL(p) 1 ML 4.11
63 Metronidazole Oral liquid 200mg/5mL(p) 1 ML 0.46
Amoxicillin (A) + Dry Syrup 125mg (A) + 31.25
64 Clavulanic acid (B) (B)/5mL(p) 1 ML 1.83
65 6-Mercaptopurine Tablet 50mg 1 Tablet 4.69
66 Cyclosporine Oral liquid 100mg/mL(p) 1 ML 71.87
67 Labetalol Injection 5mg/mL 1 ML 44.58
68 Glycopyrrolate Injection 0.2mg/mL 1 ML 12.96
69 Tranexamic acid Injection 100 mg/mL 1 ML 12.23
70 Diazepam Injection 5mg/mL 1 ML 4.94
71 Paracetamol Oral Liquid 125 mg/5 mL (p) 1 ML 0.33
72 Metoclopramide Oral liquid 5mg/5mL(p) 1 ML 0.45
73 Naloxone Injection 0.4mg/mL 1 ML 82.70
Pralidoxime chloride
74 (2-PAM) Injection 25mg/mL 1 ML 4.07
75 Neostigmine Injection 0.5mg/mL 1 ML 4.47
76 Phenobarbitone Injection 200mg/mL 1 ML 19.75
77 Trastuzumab Injection 440mg/50mL 1 Vial 48806.02
78 Bortezomib Powder for Injection 2mg 1 Vial 4691.51
79 Imatinib Tablet 400mg 1 Tablet 178.03
80 Docetaxel Powder for Injection 80mg 1 Vial 9215.98
81 Ribavirin Capsule 200 mg 1 Capsule 23.63
 Name of the
Sl. Ceiling Price
Scheduled Dosage form and strength Unit
No. (Rs.)
Formulation
82 Tranexamic acid Tablet 500 mg 1 Tablet 16.54
Levodopa (A) + Modified Release–Tablet 200mg
83 Carbidopa (B) (A) + 50mg (B) 1 Tablet 4.22
84 Amitriptyline Tablet 10mg 1 Tablet 2.13
85 Mifepristone Tablet 200mg 1 Tablet 312.96
86 Folic Acid Tablet 5 mg 1 Tablet 1.35
87 Rifampicin Capsule 150mg 1 Capsule 2.04
88 Rifampicin Capsule 300mg 1 Capsule 4.11
89 Ibuprofen Tablet 400mg 1 Tablet 1.07
90 Potassium chloride Oral liquid 500mg/5mL 1 ML 0.27
91 Lactulose Oral liquid 10 g/15mL 1 ML 1.10
92 Chloroquine Oral liquid 50mg/5mL 1 ML 0.30
93 Carbamazepine Oral liquid 100mg/5mL(p) 1 ML 0.28
94 Oxaliplatin Injection 5 mg/mL in 10 mL vial 1 Vial 1992.32
95 Proparacaine Eye Drops0.5% 1 ML 9.14
96 Paracetamol Oral Liquid 250 mg/5 mL (p) 1 ML 0.60
97 Ondansetron Oral liquid 2mg/5mL(p) 1 ML 1.12
98 Etoposide Injection 20mg/mL 1 ML 30.78
99 Tropicamide Eye drop 1 % 1 ML 8.41
100 Timolol Drops 0.5 % 1 ML 11.95
101 Mannitol Injection 20 % 1 ML 0.31
102 Glyceryl trinitrate Injection 5mg/mL 1 ML 5.52
103 Phenytoin Injection 50mg/mL 1 ML 5.31
104 Diclofenac Injection 25mg/mL 1 ML 1.51
105 N-acetylcysteine Injection 200 mg/mL 1 ML 21.08
106 Dopamine Injection 40mg/mL 1 ML 4.25
107 Streptomycin Powder for Injection 1000mg 1 Vial 9.69
108 Paracetamol Oral liquid 120 mg/5 mL (p) 1 ML 0.54
109 Clomiphenecitrate Tablet 100 mg 1 Tablet 12.44
110 Clomiphenecitrate Tablet 50mg 1 Tablet 7.88
Medroxyprogesterone
111 acetate Tablet 10 mg 1 Tablet 5.57

Note:

(a) All manufacturers of scheduled formulation, selling the branded or generic or both the
versions of scheduled formulations at a price higher than the ceiling price (plus Goods and
Services Tax as applicable) so fixed and notified by the Government, shall revise the
prices of all such formulations downward not exceeding the ceiling price specified in
column (5) in the above table plus goods and services tax as applicable, if any.
(b) All the existing manufacturers of above-mentioned scheduled formulations having MRP
lower than the ceiling price specified in column (5) in the above table plus goods and
services tax as applicable, if any, shall continue to maintain the existing MRP in
accordance with paragraph 13 (2) of the DPCO, 2013.
(c) The manufacturers may add goods and services tax only if they have paid actually or if it
is payable to the Government on the ceiling price mentioned in column (5) of the above
said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the
concerned manufacturer in accordance with the ceiling price specified in column (5) of the
above table as per provisions contained in paragraph 11 of the Drugs (Prices Control)
Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification
as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to
State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the
supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part
of the premises where he carries on business in a manner so as to be easily accessible to
any person wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both
as specified in the above table launches a new drug as per paragraph 2(1)(u) of the
DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new
drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to
the NPPA, in respect of production / import and sale of scheduled formulations in Form-III
of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to
discontinue production of above said scheduled formulation shall furnish information to the
NPPA, in respect of discontinuation of production and / or import of scheduled formulation
in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date
of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove
shall be liable to deposit the overcharged amount along with interest thereon under the
provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act,
1955.
(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of
the above table in this notification, the price order(s) fixing ceiling or retail price, if any,
issued prior to the above said date of notification, stand(s) superseded.

PN/239/107/2023/F F. No. 8(107)/2023/D.P./NPPA-Div.-II

(Mahaveer Saini)
Deputy Director (Pricing)